Synchron Partners with Team Gleason to Advance BCI Awareness

By

Disclaimer: Images on MEDWIRE.AI are AI-generated for illustrative purposes and are not affiliated with, endorsed by, or representative of any specific company, product, or technology.

Empowering the ALS Community Through Innovation

Synchron has expanded its partnership with Team Gleason, a foundation supporting people living with ALS, to raise awareness for its brain-computer interface (BCI) community. Founded by former NFL player Steve Gleason, Team Gleason shares Synchron’s mission of empowering those with paralysis through transformative technology.

Driving Neuroprosthetics Innovation

Synchron’s BCI system uses an endovascular approach, leveraging blood vessels to capture brain signals. This technology enables hands-free control of personal devices, offering new independence to individuals with severe paralysis.

Dr. Tom Oxley, CEO of Synchron, emphasized the significance of this partnership:

“By working with Team Gleason, we can amplify our BCI Community initiative and ensure people living with ALS have a voice in shaping the future of neuroprosthetics.”

Collaborative Efforts for Outreach

Team Gleason will support Synchron’s initiatives by sharing information through:

  • Newsletters
  • Support groups
  • Social media channels

This collaboration seeks to accelerate the development of BCI technology and increase participation in the BCI Community initiative.

Championing Patient-Centric Innovation

Blair Casey, Executive Director of Team Gleason, emphasized the impact of this partnership:

“The BCI Community initiative ensures that individuals with ALS can directly influence the next generation of assistive technology, keeping their needs at the forefront.”

Synchron’s groundbreaking technology and this partnership with Team Gleason represent a powerful step toward improving quality of life for those living with neurological conditions.

Follow MEDIWRE.AI for insights into groundbreaking collaborations like this and advancements in neuroprosthetics.